MARKET-DISCOVERED GROUP
Price direction is split across 20 measured members. Capital-flow confirmation is unavailable.
No session event has enough timestamp precision to place on the clock.
TUE, MAY 5COR filing documented shared operating contextrestructuring affecting expense · date precision only
TUE, JUL 28AON filing documented shared operating contextrestructuring affecting expense · date precision only
01 · WHAT IS HAPPENING
Observed intraday paths are not available for this group yet.
02 · WHY IT MATTERS
No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.
Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across AJG, AON, BFAM, ERIE, KNSL, LOPE, MH, MRSH, PRDO.
“to the acquisition of OneOncology and a $287.6 million LIFO credit, offset in part by depreciation expense of $277.5 million, amortization expense of $249.7 million, and a $249.5 million impairment of assets, including goodwill; and • An increase in inventories of $120.2 million to support the increase in business volume and due to seasonal needs; The cash used in the above items was offset in part by net income of $2.2 billion.”
COR 10-Q · 2026-05-06
“The increase in interest expense was primarily due to the issuance of our $3.0 billion of senior notes and the $1.5 billion of variable-rate term loans in February 2026, which we borrowed to finance a portion of the OneOncology acquisition, and higher interest expense at our European distribution business, offset in part by lower interest on our domestic revolving credit facility borrowings and lower interest expense on the $0.4 billion balance remaining on the $1.5 billion variable-rate term loan, which we borrowed in January 2025 to finance a portion of the RCA acquisition.”
COR 10-Q · 2026-08-05
“Our effective tax rate in fiscal 2024 was higher than the U.S. statutory rate primarily due to the PharmaLex goodwill impairment, which was largely not deductible for income tax purposes, and U.S. state income taxes, offset in part by the discrete tax benefits associated with foreign valuation allowance adjustments and the benefit of non-U.S. income taxed at rates lower than the U.S. statutory rate.”
COR 10-K · 2025-11-25
Filing-linked outsiders test whether the move is spreading beyond the established cohort.
No high-confidence filing-linked outsiders are available for this group yet.
03 · WHO IS IN IT
13/20 active8 rising · 12 falling
| TICKER | Company | Role now | Today | Observed history | Trader interpretation |
|---|---|---|---|---|---|
| MCK | McKesson Corporation | Participating | +2.5% | — | Price participation is not yet confirmed by per-name flow. |
| COR | Cencora, Inc. | Most unusual | +2.8% | — | Most unusual activity in this snapshot; performance direction may differ. |
| LAUR | Laureate Education, Inc. | Participating | -1.6% | — | Price participation is not yet confirmed by per-name flow. |
| AJG | Arthur J. Gallagher & Co. | Participating | +0.3% | — | Price participation is not yet confirmed by per-name flow. |
| PRDO | Perdoceo Education Corporation | Participating | -0.7% | — | Price participation is not yet confirmed by per-name flow. |
| LOPE | Grand Canyon Education, Inc. | Participating | -1.5% | — | Price participation is not yet confirmed by per-name flow. |
| V | Visa Inc. | Participating | +0.3% | — | Price participation is not yet confirmed by per-name flow. |
| ERIE | Erie Indemnity Company | Participating | +1.8% | — | Price participation is not yet confirmed by per-name flow. |
| MCD | McDonald's Corporation | Participating | +0.2% | — | Price participation is not yet confirmed by per-name flow. |
| HLN | Haleon plc | Participating | -0.1% | — | Price participation is not yet confirmed by per-name flow. |
| CVSA | Covista Inc. | Participating | -2.2% | — | Price participation is not yet confirmed by per-name flow. |
| MA | Mastercard Incorporated | Participating | -0.3% | — | Price participation is not yet confirmed by per-name flow. |
| RYAN | Ryan Specialty Holdings, Inc. | Quiet / lagging | -0.5% | — | Not participating yet; a breadth test or a genuine divergence. |
| BFAM | Bright Horizons Family Solutions Inc. | Quiet / lagging | -1.2% | — | Not participating yet; a breadth test or a genuine divergence. |
| MRSH | Marsh & McLennan Companies, Inc. | Participating | +0.2% | — | Price participation is not yet confirmed by per-name flow. |
| MH | McGraw Hill, Inc. | Quiet / lagging | -1.0% | — | Not participating yet; a breadth test or a genuine divergence. |
| KNSL | Kinsale Capital Group, Inc. | Quiet / lagging | +1.8% | — | Not participating yet; a breadth test or a genuine divergence. |
| PSO | Pearson plc | Quiet / lagging | -1.7% | — | Not participating yet; a breadth test or a genuine divergence. |
| AON | Aon plc | Participating | -0.2% | — | Price participation is not yet confirmed by per-name flow. |
| BRO | Brown & Brown, Inc. | Participating | -0.2% | — | Price participation is not yet confirmed by per-name flow. |
04 · HAS THIS HAPPENED BEFORE
No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.
Only 0 completed episodes across 0 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.
Historical cohort observations are not available yet.